I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Cipriani, Ludovica
13
results:
Search for persons
X
Format
Online (13)
Mediatypes
Articles (Online) (6)
OpenAccess-fulltext (7)
Sorted by: Relevance
Sorted by: Year
?
1
Humoral Response after Two Doses of BNT162b2 mRNA Vaccine H..:
Basso, Monica
;
Pirola, Nicole
;
Pascoli, Susanna
...
Vaccines. 11 (2022) 1 - p. 82 , 2022
Link:
https://doi.org/10.3390/..
?
2
COVID-19 in B Cell-Depleted Patients After Rituximab: A Dia..:
Furlan, Anna
;
Forner, Gabriella
;
Cipriani, Ludovica
...
Frontiers in Immunology. 12 (2021) - p. , 2021
Link:
https://doi.org/10.3389/..
?
3
Dramatic Response to Convalescent Hyperimmune Plasma in Ass..:
Furlan, Anna
;
Forner, Gabriella
;
Cipriani, Ludovica
...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) 9 - p. e731-e735 , 2021
Link:
https://doi.org/10.1016/..
?
4
Clinical Efficacy of Ceftolozane-Tazobactam Versus Other Ac..:
Vena, Antonio
;
Giacobbe, Daniele Roberto
;
Mussini, Cristina
...
Clinical Infectious Diseases. 71 (2020) 7 - p. 1799-1801 , 2020
Link:
https://doi.org/10.1093/..
?
5
Ceftolozane/tazobactam for the treatment of serious Pseudom..:
Bassetti, Matteo
;
Castaldo, Nadia
;
Cattelan, Annamaria
...
International Journal of Antimicrobial Agents. 53 (2019) 4 - p. 408-415 , 2019
Link:
https://doi.org/10.1016/..
?
6
Humoral Response after Two Doses of BNT162b2 mRNA Vaccine H..:
Basso, Monica
;
Pirola, Nicole
;
Pascoli, Susanna
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862719/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
7
COVID-19 in B Cell-Depleted Patients After Rituximab: A Dia..:
Furlan, Anna
;
Forner, Gabriella
;
Cipriani, Ludovica
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595333/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
8
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Produci..:
Bassetti, Matteo
;
Vena, Antonio
;
Giacobbe, Daniele Roberto
...
info:eu-repo/semantics/altIdentifier/pmid/32462046. , 2020
Link:
http://hdl.handle.net/11..
?
9
Humoral Response after Two Doses of BNT162b2 mRNA Vaccine H..:
Monica Basso
;
Nicole Pirola
;
Susanna Pascoli
...
COVID-19 Vaccines and Vaccination. , 2022
Link:
https://doi.org/10.3390/..
?
10
Humoral Response after Two Doses of BNT162b2 mRNA Vaccine H..:
Monica Basso
;
Nicole Pirola
;
Susanna Pascoli
...
info:eu-repo/semantics/altIdentifier/pmid/36679927. , 2022
Link:
https://hdl.handle.net/2..
?
11
Humoral Response after Two Doses of BNT162b2 mRNA Vaccine H..:
Monica Basso
;
Nicole Pirola
;
Susanna Pascoli
...
https://www.mdpi.com/2076-393X/11/1/82. , 2022
Link:
https://doi.org/10.3390/..
?
12
COVID-19 in B Cell-Depleted Patients After Rituximab: A Dia..:
Anna Furlan
;
Gabriella Forner
;
Ludovica Cipriani
...
https://www.frontiersin.org/articles/10.3389/fimmu.2021.763412/full. , 2021
Link:
https://doi.org/10.3389/..
?
13
An Urban Traffic Flow Model to Capture Complex Flow Interac..:
Tiriolo, Marco
;
Adacher, Ludovica
;
Cipriani, Ernesto
Procedia - Social and Behavioral Sciences. 111 (2014) - p. 839-848 , 2014
Link:
https://doi.org/10.1016/..
1-13